Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 -0.02 (-2.53%)
As of: Oct 21, 2026 · 11:49 AM EDT

Brainstorm Cell Therapeutics (BCLI) Receivables - Net (2010 - 2012)

Updated

Brainstorm Cell Therapeutics (BCLI) recorded Receivables - Net of $449,000 in Q3 2012, up 21.7% from $369,000 a year earlier and up 6.7% from the prior quarter.

Analysis

Brainstorm Cell Therapeutics (BCLI) Receivables - Net (2010 - 2012) Analysis & Trends

At the end of FY2011, Brainstorm Cell Therapeutics reported Receivables - Net of $312,000, down 26.9% from FY2010.

  • Across earlier years, Receivables - Net came in at $427,000 in FY2010.
  • Quarterly Receivables - Net has ranged from $312,000 in Q4 2011 to $482,000 in Q1 2012 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $421,000 (Q2 2012), $482,000 (Q1 2012) and $312,000 (Q4 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.82 Bn 1,135.41 Bn 19.71 Bn
2 Johnson & Johnson 644.52 Bn 564.38 Bn 17.30 Bn
3 AbbVie 501.88 Bn 474.99 Bn 12.70 Bn
4 Merck 358.72 Bn 313.10 Bn 12.21 Bn
5 Novartis Ag 302.27 Bn 266.26 Bn 11.24 Bn
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn
7 Amgen 241.67 Bn 197.07 Bn 7.24 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn
9 Pfizer 171.60 Bn 118.24 Bn 10.94 Bn
10 Brainstorm Cell Therapeutics 8.50 Mn 8.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 449,000.00
Jun 30, 2012 421,000.00
Mar 31, 2012 482,000.00
Dec 31, 2011 312,000.00
Sep 30, 2011 369,000.00
Dec 31, 2010 427,000.00
API Access

Brainstorm Cell Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=BCLI&period=max&api_key=YOUR_API_KEY